© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 14, 2015
The presence of chronic kidney disease (CKD) in patients with atrial fibrillation increases the risk of stroke and thromboembolism (TE) as well as the risk of bleeding, thus complicating their treatment. In this context, it has been suggested that CKD should be included in the CHA2DS2-VASc (Congestive heart failure; Hypertension; Age â‰¥75 years; Diabetes mellitus; previous Stroke, transient ischemic attack, or thromboembolism; Vascular disease; Age 65 to 74 years; Sex category) score.
April 16, 2014
An examination of the cost-effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation patients.
December 01, 2013
Karan Lal, DO: Eczema Awareness Month and FDA Approval of Dupilumab
High Melanoma Incidence Associated with Diagnostic Scrutiny Rather Than UV Exposure
Robert Cionni, MD: Innovations in Drug Delivery for Glaucoma Treatment